Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that the Cellfina™ System has received the 2016 Good Housekeeping Best of Beauty Awards in the Body Solution category. Cellfina™ is the only FDA-cleared minimally invasive procedure clinically proven to improve the appearance of cellulite in the buttocks and thighs of adult females, for results that last at least two years, the longest duration cleared by the FDA. Winners are featured in the May 2016 issue of Good Housekeeping Magazine.

“We are honored that Good Housekeeping has chosen to recognize Cellfina™ as one of the top beauty innovations for 2016,” said Patrick Urban, Vice President and U.S. Head of the Merz Aesthetics Device business. “We hope that this prestigious award from Good Housekeeping, coupled with our 96% patient satisfaction at 2 years, will encourage more consumers to speak with their physicians about whether treatment with Cellfina™ is right for them.”

The Good Housekeeping Beauty Breakthrough Award in the “Best Body Solutions” category honors the latest advancements, treatments, and technologies across the beauty industry. The Cellfina™ System combines highly advanced, proprietary technology with a well-established procedure called subcision, to treat the primary structural cause of cellulite.

“In my experience, almost all of the women who have cellulite are bothered by it,” said Laurie Casas, MD, board-certified plastic surgeon and Senior Clinician Educator, University of Chicago Pritzer School of Medicine. “For women seeking an improvement in the appearance of cellulite, Cellfina™ is truly a one-of-a-kind option for treating dimpled cellulite on the buttocks and thighs.”

About Cellfina™

The Cellfina™ System is intended for long-term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females. Safety and effectiveness in other anatomical areas have not been established. The most common side effects reported were soreness, tenderness, and bruising. The Cellfina™ System is only available through a licensed physician. For full product and safety information, visit

About Merz Aesthetics Device

Merz Aesthetics is a division of Merz North America, a specialty healthcare company dedicated to delivering a better total experience in aesthetics, dermatology and neurosciences. Merz Aesthetics‘ signature Device technology is Ultherapy® an FDA-cleared procedure to non-invasively lift skin on the neck, under the chin and on the eyebrow as well as to improve lines and wrinkles of the décolleté. Merz Aesthetics Device is also launching the Cellfina™ cellulite procedure, an FDA-cleared treatment intended for the long-term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females. To learn more about Merz Aesthetics and their Device offerings, please visit

Merz Pharma Group
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at

Download File:
05.09.2016 [ 0 KB ]

Press Contact

Merz North America

Emily Browder
Corporate Communications


Phone: +1 919.582.8114